Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...
With how much Goku, Vegeta, and the rest of the Saiyans have evolved since then, Raditz pales in comparison. While being Goku's biological mother might warrant some status in the Dragon Ball ...